Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1996-11-21
1998-01-27
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
A61K 3166
Patent
active
057122628
ABSTRACT:
Admisistration of sphingosine-1-phosphate to retard apoptosis in degenerative diseases as neurodegenerative disease, ischemic stroke and aging is disclosed wherein slowing of the process of programmed cell death is useful as a means to slow the degenerative process in patients suffering from these diseases.
REFERENCES:
Ohta et al., FEBS Letters (1994), 355(3), 267-70.
Carr Carol
Hendricks Glenna
Spivack Phyllis G.
LandOfFree
Use of sphingosine-1-phosphate to suppress programmed cell death does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of sphingosine-1-phosphate to suppress programmed cell death, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of sphingosine-1-phosphate to suppress programmed cell death will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342405